Fundamentals · JNJ
Distress (Altman-Z + Piotroski-F) for JNJ
AI-generated plain-English read of distress (altman-z + piotroski-f) for JNJ. Updated daily.
Healthy, deteriorating
highBoth the bankruptcy risk score (Z=3.30) and the operational health score (9/9) point to a financially sound company, trend deteriorating within the safe zone.
What will probably happen
- Still in the safe zone but the bankruptcy risk score is sliding — watch the next two quarters for confirmation of a trend reversal.
- If deterioration continues at this pace, the company could enter the grey zone within 2-3 reporting periods.
What to do
- If you HOLD this stock
- No structural action needed — both scores say the company is financially sound. Standard position management applies.
- If you are EVALUATING this stock
- Safe to initiate — balance sheet is healthy and operations are generating quality earnings.
- If you trade OPTIONS
- Distress premium is not in play here; options pricing should reflect business risk, not solvency risk. Standard volatility-based sizing.
Both scores present with ≥3 periods of bankruptcy risk history.
Technical details
Technical analysis
- Trend
- deteriorating
- Sector
- Pharmaceuticals
- Agreement
- both_healthy
- Prior-period avg Z
- 5.68
- Bankruptcy risk score (Altman-Z)
- 3.30 (safe zone)
- Operational health score (Piotroski-F)
- 9/9 (Strong (7-9)) — profitability 4/4; leverage 3/3; efficiency 2/2
Key levels
| Level | Value |
|---|---|
| latest z | 3.3 |
| prior avg z | 5.685 |
| piotroski score | 9 |
| altman safe threshold | 2.99 |
| altman distress threshold | 1.81 |